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ABSTRACT
Objective: The prolonged use of intravenous antibiotics might increase the length and cost of hospitalization. The research objective, therefore, was to 
evaluate the effect of switching antibiotics on the length of hospital stay and hospitalization cost. The prospective cohort research design was adopted. 
The inclusion criteria were in patients who had received intravenous antibiotics.
Methods: The sample comprised 39 patients who switched antibiotics as an exposed group and 39 patients who did not switch as an unexposed 
group. The data were collected using the patient medical records and the financial data from the hospital information system. The Mann–Whitney test 
and Chi-square or Fisher’s exact test was applied in the analysis.
Results: The results revealed that the antibiotics most commonly switched were intravenous ceftriaxone (83.3%) and oral cefixime (94.8%). From the 
five switching patterns observed, the most common switch was from intravenous ceftriaxone to oral cefixime in patients with acute gastroenteritis. 
All antibiotics were administered in accordance with the National Formulary (NF) guidelines. Only metronidazole (5 mg/ml dose) was inconsistent 
with NF. Switching antibiotics did not impact the length of hospital stay and hospitalization cost; however, comorbidities did have an influence here.
Conclusions: Further, switching antibiotics impacted the duration over which intravenous antibiotics were administered and the cost of antibiotics.
Keywords: Switching antibiotics, Length of stay, Cost.
INTRODUCTION
Infectious diseases are still one of the most important public 
health issues, especially in developing countries [1]. In developing 
countries, 44-97% of hospital patients are prescribed antibiotics [2]. 
Dispensing antibiotic without prescription is illegal and alarming; 
therefore, improvement on the current prescribing pattern for both 
prescribers and pharmacists is highly warranted [3]. Research on 
two educational hospitals in Indonesia showed that 84% of patients 
received antibiotics [2]. Further, 62% of all antibiotics prescribed are 
administered intravenously [2]. Antibiotics are usually administered 
intravenously at the beginning of hospitalization to provide optimal 
concentration [4]. About one-third of patients receiving antibiotics 
intravenously are eligible for switching to oral antibiotics [5,6].
Several studies have shown that antibiotics are often prescribed 
intravenously even if patients may be taking oral antibiotics [7]. If 
antibiotics are not switched at the right time, the cost of treatment 
increases [7]. Further, the duration of intravenous antibiotics is a 
major factor affecting the length of hospitalization, which is a chief 
determinant of hospital costs [4,8]. Patients receiving intravenous 
antibiotics often undergo prolonged hospitalization so that antibiotic 
treatment can be completed. Intravenous to oral switching may 
facilitate earlier patient repatriation and save maintenance costs [9]. 
The economic pressures are facing the hospital result in the length of 
stay being reduced and an increased interest in switching as well as the 
early discharge of patients [8].
Several studies have demonstrated that implementing switching 
therapy for patients requiring intravenous antibiotics successfully 
decreases the length of stay [10]. Switching antibiotics have been 
shown to significantly reduce hospital costs without sacrificing 
effectiveness or safety [11]. This phenomenon was observed in Depok 
General Hospital (DGH), the only government-owned hospital in Depok 
City, Indonesia. Due to the lack of hospitals in cooperation with the 
Social Security Administration Agency in Depok City, a large number of 
patients under National Health Insurance were referred to DGH. DGH 
is a Type C hospital with 71 beds for patient services. As DGH does 
not have microbiology laboratory, antibiotic therapy is empirically 
supported [12]. Given the limited information of antibiotic use at DGH, 
this work studied parenteral antibiotic usage patterns and the effect of 
intravenous to oral switching on the length of stay and hospitalization 
cost at DGH. The objective of this study was to evaluate the effect 
of antibiotic switching on the duration of stay and cost of patient 
hospitalization in DGH as well as to evaluate compliance with National 
Formulation (NF) guidelines.
METHODS
A prospective cohort study design was adopted, where antibiotic 
switching was performed during the treatment in the exposed group 
and antibiotics were not switched in the unexposed group. The 
inclusion criteria were patients aged 18 years and older, in internal 
medicine, neurology, and in isolation at DGH, who received antibiotics 
intravenously at the beginning of their treatment. The exclusion criteria 
were patients who presented incomplete data. This study assessed 
the effect of the independent variable, namely, antibiotic switching, to 
the dependent variables of length of hospitalization stay and inpatient 
costs, considering age, body mass index (BMI), comorbidity, and 
payment status as the confounding variables.
Medical data and patient treatment were prospectively taken from 
medical records. The data collected included the patients’ medical 
record number, name, age, gender, payment status, height and weight, 
diagnosis, prior disease history, current disease history, comorbidities, 
antibiotic regimens, clinical signs of patients, laboratory data and 
radiological examination, treatment class, length of hospitalization stay, 
and duration of intravenous antibiotics. Financial data were obtained 
from the hospital information system at DGH. These data include 
antibiotic costs, action costs (e.g., injection, infusion, nasogastric 
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tubes and urine bags, and oxygen delivery), support costs (laboratory, 
radiological, and other examinations), maintenance costs (nursing 
room and doctor visits), and the cost of other drugs and medical devices.
The data were statistically analyzed using the SPSS program. Univariate 
analysis was performed to obtain a picture of the frequency distribution 
of the variables studied, such as patient characteristics, antibiotic 
characteristics, the normality test of old data, and hospitalization costs. 
The Chi-square test or Fisher test was performed to assess the equality 
of confounding variables between the switching and non-switching 
groups. The Mann–Whitney test was conducted to assess the effect of 
the confounding variables on the dependent variables and the influence 
of the independent variable on dependent variables. Linear regression 
was used for the multivariate analysis.
RESULTS
There were 119 samples, comprising 44 patients in the switching group and 
75 patients in the non-switching group. Four patients were excluded and 
14 patients failed to follow-up. A simple random sampling was performed 
in the non-switching group to equalize the numbers between the two 
groups, such that 39 patients were obtained for each group. The patient 
characteristics are shown in Table 1, presenting the highest percentages 
in terms of gender, age, non-underweight, comorbidity (diagnosis of 
individual comorbidities ranging from 1 to 4 types of conditions), insurance 
payment status, and Class 3 care facilities. The patients were categorized on 
the basis of age group into adults—young adults between 19 and 49 years 
of age and adults between 50 and 64 years of age—and the elderly, namely, 
those who were 65 years and above [13]. The BMI group was categorized 
based on the criteria used for the Asian population: Underweight being 
below 18 kg/m2, non-underweight—comprising normal-weight patients 
between 18 and 22.9 kg/m2 and overweight patients between 23 and 
24.9 kg/m2—and obese being above 25 kg/m2 [14].
The Chi-square or Fisher’s exact test was performed to determine the 
equality of age, BMI, comorbidity, and payment status between the 
switching and non-switching groups. The results of this equality test 
are presented in Table 2.
The test results showed that there was no difference in the characteristics 
of patients between the switching and non-switching groups (p>0.05). 
As DGH does not have a microbiology laboratory and Diagnosis 
Therapy Guidance (PDT), all antibiotics are administered empirically 
on the basis of each physician’s experience. Table 3 summarizes the 
characteristics of antibiotics used in switching. The most commonly 
administered intravenous antibiotic is ceftriaxone (83.3%), followed by 
cefotaxime (6.4%).
Cefixime (94.8%) is the most commonly switched oral antibiotic 
from intravenous antibiotics. Cefixime is an oral third-generation 
cephalosporin antibiotic that shows antimicrobial activity against both 
Gram-positive and negative bacteria, including Enterobacteriaceae. 
On oral administration, nearly 50% immediately reach bactericidal 
concentrations and penetrate tissues well [2]. Table 4 summarizes the 
switching patterns from intravenous to oral antibiotics.
Doctors prescribe switching for a number of reasons: The patient could 
be free of fever, the clinical conditions could have improved, and the 
patient may be able to consume the oral medication. Each doctor has 
a different switching policy. Some doctors prescribe switching on the 
5th day of intravenous use of antibiotics. There are also doctors who 
prescribe switching based on the patient’s clinical conditions, such 
that it is done earlier. Some studies suggest that the optimal time for 
switching is the 2nd to 4th day of intravenous antibiotics [6,15,16]. 
The study did not observe any patients who relapsed or required 
intravenous antibiotics again after switching. Table 5 summarizes the 
switching of antibiotics based on the diagnosis.
Most intravenous antibiotics are used in the treatment of acute 
gastroenteritis (AGE) (37.2%), leukocytosis (19.2%), typhoid (15.4%), 
and urinary tract infections (11.5%). According to the 2013 profile data 
of DGH, age ranks second among the top 10 diseases in the inpatient 
unit, followed by typhoid.
Most of the switching was performed in the case of AGE (16 persons) 
and typhoid (10 people) patients. Most of the research on switching is 
limited to antibiotics or certain medical conditions, such as community 
pneumonia. Only a few studies have evaluated switching in the general 
Table 1: Patients’ characteristics
Characteristics Switching Non‑switching Total (%)
Gender
Male 16 19 35 (44.9)
Female 23 20 43 (55.1)
Total 39 39 78 (100.0)
Comorbidity diagnosis
Dengue hemorrhagic fever 11 3 14 (20.3)
Congestive heart failure 0 5 5 (7.2)
Dyspepsia 2 2 4 (5.8)
Others 23 23 46 (66.7)
Total 36 33 69 (100.0)
Class
Class 2 4 7 11 (14.1)
Class 3 35 32 67 (85.9)
Total 39 39 78 (100.0)
Table 2: Equality test for the confounding variables between the 
switching and non‑switching groups of infectious patients
Variables n (%) p value
Switching Non‑switching
Age
Adult 32 (82.1) 33 (84.6) 0.761a
Elderly 7 (17.9) 6 (15.4)
Total 39 (100) 39 (100)
BMI
Underweight 4 (10.3) 7 (17.9) 0.329a
Not underweight 35 (89.7) 32 (82.1)
Total 39 (100) 39 (100)
Comorbidity
Present 36 (92.3) 33 (84.6) 0.481b
None 2 (7.7) 4 (15.4)
Total 39 (100) 39 (100)
Payment methods
Assurance 33 (84.6) 30 (76.9) 0.389a
Non-assurance 6 (15.4) 9 (23.1)
Total 39 (100) 39 (100)
a,b: Significant value p > 0.05. BMI: Body mass index
Table 3: Characteristics of antibiotics
















+ - Represents combination,/- Indicates a switching antibiotic
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population of patients. These studies reported that switching was most 
common in patients with respiratory infections [5,6,15].
Switching was not performed in the case of patients with septic shock. This 
contrasts with the study by Mertz et al., which states that sepsis patients 
who switch to oral ciprofloxacin develop a fever again [15]. Further, 
monitoring of these patients indicated multiple liver abscesses. The 
patients recovered after continuing with intravenous antibiotic therapy.
DGH has implemented the National Health Insurance Program and 
adopted the NF guidelines as a reference for drug use. The suitability of 
antibiotic usage is assumed to be based on knowledge of drug selection 
based on guidelines established by both NF and the formulary of DGH, 
2013-2014. Table 6 summarizes data pertaining to the conformity of 
antibiotic usage with the NF guidelines and the formulary of DGH.
Table 6 summarizes all the antibiotics used in accordance with NF. One 
antibiotic is shown to be incompatible with the formulary of DGH 2013-
2014, namely, metronidazole 5 mg/ml. This is a good indication, implying 
that doctors have complied with both NF and the formulary of DGH, in 
addition to ensuring that the patient receives the medication prescribed 
by the hospital. The Kolmogorov–Smirnov test for normality showed that 
the distribution of inpatients and inpatient costs was not normal (p<0.05). 
Table 7 summarizes the Mann–Whitney test results pertaining to the effect 
of the confounding variables on the duration of stay and inpatient costs.
The test results are used to determine the confounding variables to 
be tested for influence on the dependent variable (length of stay and 
cost) along with the independent variables (antibiotic switching), using 
linear regression. The variables to be included in the linear regression 
analysis are those for which the bivariate analysis has a p<0.25, namely, 
comorbidity and payment status. The Mann–Whitney test is used to 
determine the effect of switching on the duration and cost of patient 
hospitalization. Table 8 summarizes the test results.
However, with the Mann–Whitney test, the change was not significant 
(p>0.05). Table 9 summarizes the results of the multivariate linear 
regression test between the independent variable (antibiotic 
switching), the dependent variables (duration and hospitalization 
cost), and the confounding factors (comorbidity and payment status). 
Further, Table 10 summarizes the effect of switching on the duration of 
intravenous antibiotics and antibiotic costs.
The average duration of intravenous antibiotics decreased significantly 
(p=0.000) from 5.67 days (non-switching group) to 3.49 days (switching 
group). Further, the average cost of antibiotics decreased significantly 
(p=0.003) from Rp. 114,781.28 (non-switching group) to Rp. 46,478.21 
(switching group).
DISCUSSION
The results showed that comorbidity had an effect on the length of stay 
and hospitalization cost. Comorbidities result in a lengthier hospital 
stay and higher hospitalization costs. This relationship can be explained 
in terms of the time needed to care for and address the patient’s illness. 
The more the diseases, the longer the treatment [17], and the higher the 
cost of hospitalization.
According to the previous research on the use of antibiotics, the most 
frequently used antibiotics were ceftriaxone (31.43%), followed by 
cefotaxime (20.95%) [18]. These are third-generation cephalosporin 
antibiotics, which have been widely used in the treatment of various 
infectious diseases caused by a broad-spectrum of antibacterial activity, 
including Gram-negative and Gram-positive bacteria.
Switching can significantly reduce the duration over which intravenous 
antibiotics are administered, but it does not reduce the length of 
hospitalization, which is influenced by comorbidity and payment status. 
Thus, even in the case of switching, the patient is not immediately discharged 
because overcoming comorbidity takes some time. A meta-analysis 
reported that five studies used specific criteria for returning patients in 
addition to switching, including no comorbid treatment or diagnostic 
examination requirements [8]. According to Mandell et al., patients can 
Table 4: Switching pattern from intravenous to oral antibiotics
Diagnosis Intravenous Oral Total
Bronchitis Ceftriaxone Cefixime 1
Fever Ceftriaxone Cefixime 2
AGE Ceftriaxone Cefixime 16




Leukocytosis Ceftriaxone Cefixime 5




+ - Indicates combination. UTI: Urinary tract infection, AGE: Acute gastroenteritis
Table 6: Compliance of antibiotics usage with NF guidelines and 
the formulary of DGH
Antibiotic NF Formulary of DGH, 2013–2014
Levofloxacin 5 mg/ml V V
Metronidazole 5 mg/ml V -
Cefixime 100 mg capsule V V
Cefotaxime 1 g V V
Ceftazidime 1 g V V
Ceftriaxone 1 g V V
Ciprofloxacin 500 mg tablet V V
V represents a match, - indicates no match, DGH: Depok General Hospital, 
NF: National Formulary
Table 5: Switching antibiotics based on diagnosis
Diagnosis Switching Non‑switching Total (%)
Bronchitis 1 1 2 (2.6)
Bronchopneumonia, 
UTI
0 5 5 (6.4)
Fever 0 1 1 (1.3)
AGE 2 1 3 (3.8)
UTI 16 13 29 (37.2)
Leukocytosis 4 5 9 (11.5)
Suspect tuberculosis 5 10 15 (19.2)
Shock sepsis 1 0 1 (1.3)
Typhoid 0 1 1 (1.3)
10 2 12 (15.4)
Total 39 39 78 (100.0)
UTI: Urinary tract infection, AGE: Acute gastroenteritis
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and the effects of switching in decreasing the length and cost of 
patient hospitalization. Future, studies should also research switching 
by limiting the type of antibiotics, medical conditions, or duration of 
intravenous antibiotics. A recommendation for DGH is to prepare a set 
of guidelines for the prescription and administration of antibiotics. 
Pharmacists in DGH should be alert and prevent the excessive 
administration of intravenous antibiotics.
CONCLUSION
The most common antibiotics used for switching were intravenous 
ceftriaxone and oral cefixime. Five switching patterns were observed, 
most commonly from intravenously administering ceftriaxone to 
orally administering cefixime in patients with AGE. All antibiotics were 
used in accordance with the NF guidelines, although one antibiotic 
(metronidazole 5 mg/ml) was found to be incompatible with the 
guidelines of the formulary of DGH. Switching antibiotics was found 
to have no significant effect on the duration and cost of hospitalization 
among patients at DGH, although comorbidity did have a significant 
effect. Switching antibiotics only affects the duration over which they 
are administered and their cost.
REFERENCES
1. Peraturan Menteri Kesehatan RI No. 2406/Menkes/Per/XII/2011. 
Tentang Pedoman Umum Penggunaan Antibiotik.
2. Hadinegoro SR, Tumbelaka AR, Satari HI. Pengobatan cefixime pada 
demam tifoid anak. Sari Pediatr 2001;2(4):182-7.
3. Abasaeed AE, Vlcek J, Abuelkhair MA, Andrajati R, Elnour AA. 
A comparative study between prescribed and over-the-counter 
antibiotics. Saudi Med J 2013;34(10):1048-54.
4. Oosterheert JJ, Bonten MJ, Schneider MM, Buskens E, Lammers JW, 
Hustinx WM, et al. Effectiveness of early switch from intravenous to 
oral antibiotics in severe community acquired pneumonia: Multicentre 
randomised trial. BMJ 2006;333(7580):1193.
5. McLaughlin CM, Bodasing N, Boyter AC, Fenelon C, Fox JG, 
Seaton RA. Pharmacy-implemented guidelines on switching 
from intravenous to oral antibiotics: An intervention study. QJM 
2005;98(10):745-52.
6. Shrayteh ZM, Rahal MK, Malaeb DN. Practice of switch from 
intravenous to oral antibiotics. Springerplus 2014;3:717.
7. Ho BP, Lau TT, Balen RM, Naumann TL, Jewesson PJ. The impact of a 
pharmacist-managed dosage form conversion service on ciprofloxacin 
usage at a major Canadian teaching hospital: A pre-and post-intervention 
study. BMC Health Serv Res 2005;5:48.
8. Rhew DC, Tu GS, Ofman J, Henning JM, Richards MS, Weingarten SR. 
Table 7: The effect of confounding variables on the length of 
hospitalization and cost of treatment






Adult 65 5.69~6 2.24 0.591
Elderly 13 5.92~6 2.18
BMI
Underweight 11 5.91~6 2.62 0.907
Not underweight 67 5.70~6 2.17
Comorbidity
Present 69 6.01~6 2.19 0.000
None 9 3.56~4 0.73
Payment methods
Assurance 63 5.95~6 2.29 0.052
Non-assurance 15 4.80~5 1.66
Cost (rupiah)
Age
Adult 65 2621.780 1849.116 0.433
Elderly 13 2832.572 1408.100
BMI
Underweight 11 2806.242 1621.443 0.651
Not underweight 67 2632.396 1811.281
Comorbidity
Present 69 2874.471 1774.747 0.000
None 9 988.959 278.168
Payment methods
Assurance 63 2739.944 1679.054 0.109
Non-assurance 15 2308.181 2172.142
BMI: Body mass index
Table 8: Effect of switching on the length of stay and cost of 
treatment




Switching group 39 5.56~6 2.1 0.619
Non-switching group 39 5.89~6 2.35
Cost (rupiah)
Switching group 39 2400.980 1340.565 0.475
Non-switching group 39 2912.844 2113.276
Table 9: Relationship between independent variables, 
dependent variables, and confounding variables with respect to 
patients’ treatment
Variables B Beta p R2
Duration
Comorbidity –2.422 –0.351 0.001 0.165
Payment status –1.099 –0.196 0.067
Cost
Antibiotic switching 66,6563.58 0.189 0.082 0.152
Comorbidity –2.011 –0.364 0.001
be discharged as soon as their clinical condition is stable, they present no 
active medical problems, and have a safe environment in which to continue 
therapy [19]. Switching can also reduce the cost of antibiotics significantly 
but does not reduce hospitalization costs. This is due to the presence of 
comorbidities. Thus, even though the cost of antibiotics is reduced, other 
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to combat the comorbidities. The results of this study are consistent with 
some previous works. For example, according to a study in Switzerland [9], 
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antibiotics. However, the decrease in the length of hospitalization was 
not found to be statistically significant. A retrospective observational 
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shorter than in the switching group, but these results were not significant 
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severe community-acquired pneumonia patients in the Netherlands. The 
study reported that switching antibiotics can significantly reduce the 
duration of intravenous administration and the length of hospitalization.
Suggestions for further research include the need to examine the role 
of clinical pharmacists in intravenous to oral switching of antibiotics 
Table 10: The effects of switching against the length and cost of 
using antibiotics among patients
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